|
Variables
|
Overall Survival
|
Cancer-Specific Survival
|
|---|
|
3-year (%)
|
5-year (%)
|
3-year (%)
|
5-year (%)
|
|---|
|
Age, years
|
|
< 50
|
73.4
|
66.3
|
74.4
|
67.8
|
|
50–60
|
82.0
|
73.7
|
82.9
|
75.3
|
|
> 60
|
76.4
|
70.2
|
78.6
|
73.4
|
|
Tumor size, cm
|
|
≤ 12
|
77.4
|
72.8
|
79.0
|
75.0
|
|
> 12
|
78.4
|
68.4
|
79.6
|
70.4
|
|
Race
|
|
White
|
79.2
|
72.5
|
80.7
|
74.8
|
|
Black
|
57.7
|
40.3
|
61.3
|
42.8
|
|
Other
|
76.8
|
68.8
|
77.4
|
70.0
|
|
Laterality
|
|
Unilateral
|
81.8
|
75.1
|
83.1
|
77.2
|
|
Bilateral
|
46.4
|
35.5
|
48.4
|
37.1
|
|
AJCC Stage (7th)
|
|
I
|
91.2
|
85.6
|
92.2
|
87.2
|
|
II
|
76.9
|
74.5
|
78.3
|
–
|
|
III
|
46.7
|
34.1
|
49.0
|
35.8
|
|
IV
|
40.8
|
27.9
|
41.7
|
30.5
|
|
Grade
|
|
I/II
|
85.4
|
73.6
|
86.3
|
79.2
|
|
III
|
75.9
|
67.4
|
77.0
|
69.2
|
|
IV
|
78.5
|
75.0
|
80.9
|
77.3
|
|
Unknown
|
–
|
–
|
–
|
–
|
|
LN dissected, n
|
|
No
|
64.1
|
59.7
|
66.7
|
63.3
|
|
1–10
|
78.4
|
70.6
|
79.6
|
72.7
|
|
> 10
|
83.1
|
75.1
|
84.2
|
76.6
|
|
LN
|
|
No dissection or Negative
|
78.5
|
70.7
|
79.9
|
72.6
|
|
Positive
|
72.5
|
69.8
|
74.3
|
70.1
|
|
Organ Metastasis
|
|
No
|
79.0
|
71.8
|
80.5
|
73.9
|
|
Yes
|
30.5
|
22.2
|
30.5
|
26.7
|
|
Radiotherapy
|
|
No/Unknown
|
78.0
|
70.7
|
79.5
|
72.9
|
|
Yes
|
66.4
|
33.2
|
66.4
|
–
|
|
Chemotherapy
|
|
No/Unknown
|
80.5
|
76.1
|
83.4
|
80.5
|
|
Yes
|
77.2
|
69.4
|
78.4
|
71.1
|
- AJCC American Joint Committee on Cancer, LN lymph node
